Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 119,942 shares at $161.20 ($19.3M) on 2019-03-20, disclosed to the SEC on 2019-03-20.
Open-market sale of $19.3M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $161.01 | 875 | $141K | 0.7% |
| 2 | $161.01 | 875 | $141K | 0.7% |
| 3 | $161.01 | 900 | $145K | 0.7% |
| 4 | $161.02 | 800 | $129K | 0.7% |
| 5 | $161.02 | 800 | $129K | 0.7% |
| 6 | $161.14 | 1,200 |
| $193K |
| 1.0% |
| 7 | $161.14 | 1,200 | $193K | 1.0% |
| 8 | $161.20 | 16,182 | $2.6M | 13.5% |
| 9 | $161.20 | 16,182 | $2.6M | 13.5% |
| 10 | $161.32 | 13,096 | $2.1M | 10.9% |
| 11 | $161.32 | 13,096 | $2.1M | 10.9% |
| 12 | $161.32 | 14,321 | $2.3M | 11.9% |
| 13 | $161.32 | 14,321 | $2.3M | 11.9% |
| 14 | $161.35 | 13,047 | $2.1M | 10.9% |
| 15 | $161.35 | 13,047 | $2.1M | 10.9% |
| Total | $161.28 avg | 119,942 | $19.3M | 100% |
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |